Loading organizations...
§ Private Profile · Eagan, MN, USA
Medical device company developing AI-powered platforms for remote cardiac arrhythmia detection and monitoring for cardiac care.
Infobionics has raised $17.0M across 1 funding round.
Infobionics has raised $17.0M in total across 1 funding round.
Infobionics, based in Lowell, Massachusetts, USA, develops cloud-based, AI-powered platforms for remote cardiac arrhythmia detection and monitoring, utilizing wearable sensors and full disclosure models. Its MoMe Kardia system streams real-time ECG data, designed to enable faster diagnosis for clinicians, potentially reducing detection times from weeks to as little as 24 hours. The company is reportedly expanding its focus into virtual telemetry and monitoring for other chronic diseases beyond cardiac care. As a closely held private medical device company, specific details regarding funding, revenue, employee count, or valuation are not publicly disclosed, though its MoMe Kardia system received FDA clearance in March 2016, with commercial launch in Q4 of that year. Key individuals associated with Infobionics include CEO Stuart Long, and founders Dr. Jeremy Ruskin, Nancy Briefs, and Ravi Kapur. Infobionics was founded in 2012.
Infobionics has raised $17.0M in total across 1 funding round.
Infobionics's investors include Safeguard Scientifics, Beta Fund, Boardwalk Investment, Boynton, Broadview Ventures, Cherrystone Angels, HTC, Keiretsu Forum, Launchpad Venture Group, Mass Medical Angels, TiE.
Infobionics has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series B in April 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 9, 2014 | $17M Series B | Safeguard Scientifics | Beta Fund, Boardwalk Investment, Boynton, Broadview Ventures, Cherrystone Angels, HTC, Keiretsu Forum, Launchpad Venture Group, Mass Medical Angels, TIE | Announced |